WASHINGTON:The U.S. Food and Drug Administration (FDA) has approved expanded use of Emergent BioSolutions’ ACAM2000 smallpox vaccine to include people at high risk for mpox infection, the company said on Thursday.Earlier this month, the World Health Organization declared mpox a global public health emergency for the second time in two years as a new variant of the virus, known as clade Ib, spread rapidly in Africa.The FDA’s approval follows Emergent’s application for an Emergency Use Listing of ACAM2000 vaccine with the WHO.Emergent last week said it would donate 50,000 doses of its smallpox vaccine to the Democratic Republic of the Congo and other impacted countries of Burundi, Kenya, Rwand
Hence then, the article about us fda approves emergent s smallpox vaccine for people at high risk of mpox was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( US FDA approves Emergent’s smallpox vaccine for people at high risk of mpox )